Evidence map›Paper›PMID 25364658›Full record

ArticleAdvanced pharmaceutical bulletin2014

Antitumor activity of kielmeyera coriacea leaf constituents in experimental melanoma, tested in vitro and in vivo in syngeneic mice.

Carlos Rogério Figueiredo, Alisson Leonardo Matsuo, Mariana Hiromi Massaoka, Natalia Girola, Ricardo Alexandre Azevedo, Aline Nogueira Rabaça, Camyla Fernandes Farias, Felipe Valença Pereira, Natalia Silva Matias, Luciana Pereira Silva and 4 more

Open access · greenAbstract read
In one paragraph

Article in Advanced pharmaceutical bulletin, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Toxic Potential of Cerrado Plants on Different Organisms.International journal of molecular sciences · 2022
    Review
  5. Chemical Composition ofPlants (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. Therapeutic Efficacy ofBiomolecules · 2020
    Article
  9. Article
  10. Inhibitory Effect ofBioMed research international · 2019
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Carlos Rogério FigueiredoDepartment of Microbiology, Immunology and Parasitology, Experimental Oncology Unit (UNONEX), Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Alisson Leonardo MatsuoDepartment of Microbiology, Immunology and Parasitology, Experimental Oncology Unit (UNONEX), Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Mariana Hiromi MassaokaDepartment of Microbiology, Immunology and Parasitology, Experimental Oncology Unit (UNONEX), Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Natalia GirolaDepartment of Microbiology, Immunology and Parasitology, Experimental Oncology Unit (UNONEX), Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Ricardo Alexandre AzevedoDepartment of Microbiology, Immunology and Parasitology, Experimental Oncology Unit (UNONEX), Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Aline Nogueira RabaçaDepartment of Microbiology, Immunology and Parasitology, Experimental Oncology Unit (UNONEX), Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Camyla Fernandes FariasDepartment of Microbiology, Immunology and Parasitology, Experimental Oncology Unit (UNONEX), Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Felipe Valença PereiraDepartment of Microbiology, Immunology and Parasitology, Experimental Oncology Unit (UNONEX), Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Natalia Silva MatiasDepartment of Biological Sciences - Laboratory of Herbal Medicines, Universidade Estadual Paulista (UNESP- FLC/Assis), São Paulo, Brazil.
Luciana Pereira SilvaDepartment of Biological Sciences - Laboratory of Herbal Medicines, Universidade Estadual Paulista (UNESP- FLC/Assis), São Paulo, Brazil.
Elaine Guadelupe RodriguesDepartment of Microbiology, Immunology and Parasitology, Experimental Oncology Unit (UNONEX), Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
João Henrique Guilardi LagoInstitute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo (UNIFESP), Diadema, São Paulo, SP, Brazil.
Luiz Rodolpho TravassosDepartment of Microbiology, Immunology and Parasitology, Experimental Oncology Unit (UNONEX), Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Regildo Márcio Gonçalves SilvaDepartment of Biological Sciences - Laboratory of Herbal Medicines, Universidade Estadual Paulista (UNESP- FLC/Assis), São Paulo, Brazil.
Universidade Federal de São Paulo · BRUniversidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe antitumor activity of Kielmeyera coriacea (Clusiaceae), a medicinal plant used in the treatment of parasitic, as well as fungal and bacterial infections by the Brazilian Cerrado population, was investigated.

methodsA chloroform extract (CE) of K. coriacea was tested in the murine melanoma cell line (B16F10-Nex2) and a panel of human tumor cell lines. Tumor cell migration was determined by the wound-healing assay and the in vivo antitumor activity of CE was investigated in a melanoma cell metastatic model. 1H NMR and GC/MS were used to determine CE chemical composition.

resultsWe found that CE exhibited strong cytotoxic activity against murine melanoma cells and a panel of human tumor cell lines in vitro. CE also inhibited growth of B16F10-Nex2 cells at sub lethal concentrations, inducing cell cycle arrest at S phase, and inhibition of tumor cell migration. Most importantly, administration of CE significantly reduced the number of melanoma metastatic nodules in vivo. Chemical analysis of CE indicated the presence of the long chain fatty compounds, 1-eicosanol, 1-docosanol, and 2-nonadecanone as main constituents.

conclusionThese results indicate that K. coriacea is a promising medicinal plant in cancer therapy exhibiting antitumor activity both in vitro and in vivo against different tumor cell lines.

Indexed as

Anti-tumorCancerCell cycle arrestCell migrationCerradoCytotoxic

Identifiers

PMID25364658
PMCPMC4213781
OpenAlexW2122551945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.